Stemtech Expands into $303 Billion Pet Healthcare Market with Launch of Stempets(TM) Page 1

NAPLES, FL / ACCESSWIRE / August 22, 2024 / Stemtech Corporation (OTCQB;STEK), a leader in the development and distribution of human stemceuticals since 2005, is proud to announce an exciting new product line for the pet healthcare industry with the launch of “StemPets”. This revolutionary product is designed to provide substantial health benefits to dogs, cats and other beloved pets, tapping into the $303 billion pet healthcare market.

Recognizing the deep love people have for their pets and the significant expense they incur to keep them healthy, Stemtech has developed StemPets. This natural stemceuticals product promises to provide the same amazing health benefits to pets as our human products have for nearly two decades.